A retrospective study compared progression-free and overall survival of hyperthermic intraperitoneal chemotherapy with conventional intraperitoneal chemotherapy in patients with ovarian cancer.
“We have run out of chemotherapy options for this patient, so we have referred them for surgical evaluation to see if cytoreductive surgery and HIPEC is an option.” Clearly not all patients with PM ...
Validity of the Patient-Reported Outcome Measurement Information System (PROMIS) Sexual Interest and Satisfaction Measures in Men Following Radical Prostatectomy Compared with CRSa, CRS-HIPEC improved ...
CHICAGO — Intraperitoneal (IP) chemotherapy is now an alternative to intravenous (IV) administration that "must be discussed" for women with cytoreduced ovarian cancer, several experts said here at ...
FOX CHASE (WPVI) -- HIPEC is an often overlooked form of chemotherapy, with a long track record. It's improving survival rates in some abdominal cancers, however, some patients and doctors may not ...
A new guideline from ASCO updates evidence-based recommendations on the use of neoadjuvant chemotherapy and interval cytoreduction versus primary cytoreductive surgery (PCS) and chemotherapy in ...
A Q&A with Michael Foote, MD, MSK Gastrointestinal Medical Oncologist and member of the Peritoneal Surface Malignancies Consortium Group The Peritoneal Surface Malignancies Consortium Group (PSM ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback